DEFA14A: Immunome, Inc. Sets Date for 2024 Annual Meeting, Outlines Proposals for Stockholder Vote
Proxy Statement
Immunome, Inc. announces its 2024 Annual Meeting of Stockholders to be held virtually on June 12, 2024, with key proposals including the election of directors and ratification of the company's independent auditor.
Summary
- Immunome, Inc. is holding its 2024 Annual Meeting of Stockholders on June 12, 2024, at 8:30 AM Pacific Time.
- The meeting will be held virtually at www.virtualshareholdermeeting.com/IMNM2024.
- Stockholders are being asked to vote on the election of two Class I director nominees, Clay B. Siegall, Ph.D., and Carol Schafer, to serve until the 2027 annual meeting.
- Another proposal is to ratify the appointment of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Stockholders can vote online at www.ProxyVote.com or request a paper or email copy of the proxy materials before May 29, 2024.
Sentiment
Score: 7
Explanation: The document is a standard proxy statement, indicating a neutral sentiment focused on procedural matters.
Positives
- The virtual format of the annual meeting allows for broader accessibility for stockholders.
- Stockholders have multiple options for accessing proxy materials and voting, including online, by phone, and by email.
Future Outlook
The document outlines the standard procedures for an annual meeting, focusing on governance and compliance requirements.
Industry Context
This announcement is a routine part of corporate governance, ensuring that stockholders have the opportunity to vote on key company matters.
Stakeholder Impact
- Shareholders are directly impacted through their voting rights on key company decisions.
- The outcome of the votes will influence the composition of the Board of Directors and the selection of the company's auditor.
Next Steps
- Stockholders to review proxy materials and vote on the proposals.
- Immunome to conduct the Annual Meeting on June 12, 2024.
Key Dates
| Date | Description |
|---|---|
| May 29, 2024 | Deadline to request a paper or email copy of proxy materials. |
| June 11, 2024 | Voting deadline at 8:59 PM PT. |
| June 12, 2024 | Date of the Annual Meeting at 8:30 AM PT. |
| December 31, 2024 | End of the fiscal year for which Ernst & Young LLP is proposed as the independent auditor. |
| 2027 | Year until which the Class I director nominees, if elected, will hold office. |
Keywords
Annual Meeting, Proxy Statement, Stockholders, Immunome, Directors, Auditor, Voting
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.